Heparin therapy in COVID-19: Call for randomized controlled trials (RCTs)
{{output}}
Coronavirus disease 2019 (COVID-19) is associated with increases in abnormal coagulation, and particularly D-dimer (D-D) levels. Heparin therapy has been recommended as pharmacologic thromboprophylaxis in patients hospitalized with COVID-19; however, data on i... ...
